It was a rough end to the week for cannabis companies, but there were a few budding stocks this afternoon.
CV Sciences Inc (OTCQX:CVSI) was a top gainer on the North American Marijuana Index.
READ: CryptoCann™ Report: Intel files patent for energy-efficient Bitcoin mining; Study finds fewer opioid overdoses in places with marijuana dispensaries
Shares of the cannabis-focused life-science company were up about 8% to US$5.31.
The company operates cannabis facilities across multiple states, including its home base in Massachusetts, as well as Delaware and Nevada.
GW Pharmaceuticals PLC (NASDAQ:GWPH) shares climbed about 1% to US$122.99.
The company recently reported positive results from a second Phase 3 trial of its cannabis-based Epidiolex, a treatment for a severe form of childhood epilepsy.
Most of the North American cannabis stocks were in the red this afternoon.
The North American Marijuana Index, which tracks the leading cannabis stocks in the US and Canada, slipped about 1.4%.
The Vancouver-based company develops hemp-based consumer products and solutions in Canada, Latin America, Asia, and Europe.
The cannabis company recently announced that it had completed its asset acquisition of ebbu Inc, a hemp-focused research company.
Contact Lenore Fedow at firstname.lastname@example.org